Schedule 13D ownership disclosure
REGENERX BIOPHARMACEUTICALS CO
Security class unavailable · CUSIP: 75886X108
Event date: 2014-03-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 25,083,333
- Percent of class
- 23.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001596770-14-000030
- Form type
- SC 13D
- Filer
- G-treeBNT Co., Ltd.
- CIK
- CIK 1602801
- Filed
- Apr 01, 2014
- Reporting period
- Mar 28, 2014
- Description
- Schedule 13D beneficial ownership